Wells Fargo’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
VPM
VCM
Wells Fargo's GH Position: Q1 2026 in Review
Wells Fargo reduced its Guardant Health (GH) stake by 57% in Q1 2026, selling an estimated $12.2M and leaving 92,549 shares worth $8.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2164.
Wells Fargo first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $216M in Q1 2021. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.
- Wells Fargo held 92,549 shares of Guardant Health worth $8.55M as of Q1 2026.
- Wells Fargo sold 121,628 Guardant Health shares in Q1 2026, an estimated $12.2M.
- Guardant Health made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2164 holding.
- Wells Fargo first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
- Wells Fargo's Guardant Health position peaked at $216M in Q1 2021.
- 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.